These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 6085754

  • 21. Comparative antineoplastic activity against P388 leukemia of 9-beta-D-arabinofuranosyladenine (araA) and 9-beta-(2'-azido-2'-deoxy-D-arabinofuranosyl) adenine (arazide).
    Lee SH, Thomas LK, Unger FM, Christian R, Sartorelli AC.
    Int J Cancer; 1981 May 15; 27(5):703-8. PubMed ID: 6974703
    [No Abstract] [Full Text] [Related]

  • 22. Mechanism of decrease of protein synthesis by sodium cyanate in murine P388 leukemia cells.
    Lazarus P, Panasci LC.
    Cancer Res; 1987 Oct 01; 47(19):5102-7. PubMed ID: 3621195
    [Abstract] [Full Text] [Related]

  • 23. [The effect of 3,4-disuccinyldianhydrogalactitol, N-nitrosourea and their combination on DNA synthesis in normal and mouse P388 tumor cells].
    Sokolova IS, Veres Z, Jakus J, Otvos LL, Gorbacheva LB.
    Izv Akad Nauk SSSR Biol; 1989 Oct 01; (4):527-33. PubMed ID: 2794230
    [Abstract] [Full Text] [Related]

  • 24. [Mechanisms of the antitumor action of spirobromine in mice with leukemia P-388].
    Sokolova IS, Riabokon' NA, Chernov VA, Gorbacheva LB.
    Izv Akad Nauk SSSR Biol; 1989 Oct 01; (5):660-5. PubMed ID: 2584530
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of macromolecular synthesis in P388 mouse leukemia ascites cells by bouvardin (NSC 259968).
    Chitnis M, Menon R, Adwankar M, Satyamoorthy K.
    Tumori; 1985 Jun 30; 71(3):261-6. PubMed ID: 4024280
    [Abstract] [Full Text] [Related]

  • 26. Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells.
    Barrueco JR, Jacobsen DM, Chang CH, Brockman RW, Sirotnak FM.
    Cancer Res; 1987 Feb 01; 47(3):700-6. PubMed ID: 3802076
    [Abstract] [Full Text] [Related]

  • 27. Studies on the mechanism of action of 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193)--II. Relationship between dose level and biochemical effects in P388 leukemia in vivo.
    Jayaram HN, Smith AL, Glazer RI, Johns DG, Cooney DA.
    Biochem Pharmacol; 1982 Dec 01; 31(23):3839-45. PubMed ID: 6130768
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Cellular retention of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and the pattern of recovery of DNA synthesis in Chinese hamster ovary cells.
    Shewach DS, Plunkett W.
    Cancer Res; 1986 Apr 01; 46(4 Pt 1):1581-4. PubMed ID: 2418951
    [Abstract] [Full Text] [Related]

  • 30. Pharmacokinetics of 2-F-ara-A (9-beta-D-arabinofuranosyl-2-fluoroadenine) in cancer patients during the phase I clinical investigation of fludarabine phosphate.
    Malspeis L, Grever MR, Staubus AE, Young D.
    Semin Oncol; 1990 Oct 01; 17(5 Suppl 8):18-32. PubMed ID: 1699279
    [Abstract] [Full Text] [Related]

  • 31. Tumor pharmacokinetics of hexamethylmelamine in CDF1 mice bearing P388 leukemia.
    Dubois J, Atassi G, Hanocq M, Abikhalil F.
    Anticancer Res; 1989 Oct 01; 9(1):255-9. PubMed ID: 2495757
    [Abstract] [Full Text] [Related]

  • 32. Effect of bouvardin (NSC 259968) on the growth characteristics an nucleic acids and protein syntheses profiles of P388 leukemia cells.
    Chitnis MP, Alate AD, Menon RS.
    Chemotherapy; 1981 Oct 01; 27(2):126-30. PubMed ID: 7471902
    [Abstract] [Full Text] [Related]

  • 33. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.
    White EL, Shaddix SC, Brockman RW, Bennett LL.
    Cancer Res; 1982 Jun 01; 42(6):2260-4. PubMed ID: 7042080
    [Abstract] [Full Text] [Related]

  • 34. Pharmacology of fludarabine phosphate after a phase I/II trial by a loading bolus and continuous infusion in pediatric patients.
    Avramis VI, Champagne J, Sato J, Krailo M, Ettinger LJ, Poplack DG, Finkelstein J, Reaman G, Hammond GD, Holcenberg JS.
    Cancer Res; 1990 Nov 15; 50(22):7226-31. PubMed ID: 1699658
    [Abstract] [Full Text] [Related]

  • 35. Cytotoxic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5-monophosphate (fludarabine, NSC 312887) in a human tumor cloning system.
    Lathan B, Diehl V, Clark GM, von Hoff DD.
    Eur J Cancer Clin Oncol; 1988 Dec 15; 24(12):1891-5. PubMed ID: 2464493
    [Abstract] [Full Text] [Related]

  • 36. Phase II trial of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in non-Hodgkin's lymphoma: prospective comparison of response with deoxycytidine kinase activity.
    Leiby JM, Snider KM, Kraut EH, Metz EN, Malspeis L, Grever MR.
    Cancer Res; 1987 May 15; 47(10):2719-22. PubMed ID: 2436757
    [Abstract] [Full Text] [Related]

  • 37. The utilization of nucleotides by animal cells.
    Cohen SS, Plunkett W.
    Ann N Y Acad Sci; 1975 Aug 08; 255():269-86. PubMed ID: 1059361
    [Abstract] [Full Text] [Related]

  • 38. Comparison between the plasma and intracellular pharmacology of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in patients with relapsed leukemia.
    Danhauser L, Plunkett W, Liliemark J, Gandhi V, Iacoboni S, Keating M.
    Leukemia; 1987 Sep 08; 1(9):638-43. PubMed ID: 3478543
    [Abstract] [Full Text] [Related]

  • 39. Comparative effects of the 5'-triphosphates of 9-beta-(2'-azido-2'-deoxy-D-arabinofuranosyl)adenine and 9-beta-D-arabinofuranosyladenine on DNA polymerases from L1210 leukemia cells.
    Allaudeen HS, Kozarich JW, Sartorelli AC.
    Nucleic Acids Res; 1982 Feb 25; 10(4):1379-87. PubMed ID: 6175955
    [Abstract] [Full Text] [Related]

  • 40. In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis.
    Kano Y, Akutsu M, Tsunoda S, Suzuki K, Ichikawa A, Furukawa Y, Bai L, Kon K.
    Leukemia; 2000 Mar 25; 14(3):379-88. PubMed ID: 10720130
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.